日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dysregulated expression of cell cycle regulators CDC20, PLK1, BUB1, CDC45, CDCA5 in pancreatic ductal adenocarcinoma

胰腺导管腺癌中细胞周期调节因子 CDC20、PLK1、BUB1、CDC45、CDCA5 的表达失调

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-37399-w
Naeem, Maryam; Qadeer, Kainat; Jabeen, Ishrat; Ahmed, Ibrar; Murtaza, Iram; Farooq, Javeria; Sultan, Aneesa
肿瘤
PLK1
肿瘤免疫
BUB1
CDC45
CDC20
细胞生物学
CDCA5
发表日期：2026
文献求助 收藏

CDCA5 knockdown potentiates olaparib sensitivity in BRCA1-mutated ovarian cancer through autophagy activation.

CDCA5 敲低通过自噬激活增强 BRCA1 突变卵巢癌对奥拉帕尼的敏感性。

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-03610-z
Wu Wenzong, Wu Huan, Song Yuqing, Wu LiuJun, Chen Jiajia, Zhu Minsheng, Wu Xinchun, Wang Jiawei, Zhang Qingsong
卵巢癌
表观遗传
BRCA1
CDCA5
Autophagy
自噬
发表日期：2025
文献求助 收藏

Corrigendum to "SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway" [Neoplasia (2021) 23, 1037-1047]

对“SPOP促进CDCA5降解以通过AKT通路调节前列腺癌进展”的更正[Neoplasia (2021) 23, 1037-1047]

期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2024.101011
Luo, Zhenzhen; Wang, Jing; Zhu, Yue; Sun, Xiao; He, Chenchen; Cai, Mengjiao; Ma, Jinlu; Wang, Yi; Han, Suxia
肿瘤
肿瘤免疫
信号转导
SPOP
前列腺癌
CDCA5
AKT
发表日期：2024
文献求助 收藏

CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1

CDCA5通过促进E2F1和FOXM1的结合来加速乳腺癌的进展。

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-024-05443-w
Xiong, Yiquan; Shi, Lan; Li, Lei; Yang, Wen; Zhang, Huiqiong; Zhao, Xiangwang; Shen, Na
肿瘤
肿瘤免疫
FOXM1
E2F1
乳腺癌
CDCA5
发表日期：2024
文献求助 收藏

The impact of CDCA5 expression on the immune microenvironment and its potential utility as a biomarker for PD-L1/PD-1 inhibitors in lung adenocarcinoma

CDCA5表达对免疫微环境的影响及其作为肺腺癌PD-L1/PD-1抑制剂生物标志物的潜在应用

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2024.102024
Koh, Young Wha; Hwang, Yoonjung; Lee, Seul-Ki; Han, Jae-Ho; Haam, Seokjin; Lee, Hyun Woo
CDCA5
免疫/内分泌
PD-L1
肿瘤
PD-1
肿瘤免疫
发表日期：2024
文献求助 收藏

Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer Analysis

通过泛癌分析，整合多组学分析鉴定出 CDCA5 为结肠癌中与选择性剪接、肿瘤微环境和细胞增殖相关的新型生物标志物。

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.91082
Bao, Xinyue; Leng, Xin; Yu, Tianyu; Zhu, Junzheya; Zhao, Yunhan; Tenzindrogar; Yang, Zhiluo; Wu, Shaobo; Sun, Qi
肿瘤
肠癌
肿瘤免疫
细胞生物学
CDCA5
肿瘤微环境
发表日期：2024
文献求助 收藏

Finding key genes (UBE2T, KIF4A, CDCA3, and CDCA5) co-expressed in hepatitis, cirrhosis and hepatocellular carcinoma based on multiple bioinformatics techniques

基于多种生物信息学技术，寻找在肝炎、肝硬化和肝细胞癌中共表达的关键基因（UBE2T、KIF4A、CDCA3 和 CDCA5）。

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-024-03288-7
Zhang, Yingai; Yu, Weiling; Zhou, Shuai; Xiao, Jingchuan; Zhang, Xiaoyu; Yang, Haoliang; Zhang, Jianquan
肿瘤
肿瘤免疫
细胞生物学
KIF4A
肝硬化
UBE2T
CDCA5
肝炎
发表日期：2024
文献求助 收藏

Retracted: lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression

撤稿：lncRNA MIR4435-2HG 通过增强 IQGAP3 和 CDCA5 表达加速膀胱癌的发生发展

期刊:Biomed Research International
影响因子:2.3
doi:10.1155/2024/9783095
International, BioMed Research
肿瘤
肿瘤免疫
lncRNA
CDCA5
膀胱癌
发表日期：2024
文献求助 收藏

[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway

【更正】CDCA5通过影响ERK信号通路促进前列腺癌的进展

期刊:Oncology Reports
影响因子:3.9
doi:10.3892/or.2023.8602
Ji, Junpeng; Shen, Ianyu; Li, Yang; Liu, Yixi; Shang, Zhiqun; Niu, Yuanjie
肿瘤
肿瘤免疫
信号转导
MAPK/ERK
CDCA5
前列腺癌
发表日期：2023
文献求助 收藏

The Comprehensive Analysis Illustrates the Role of CDCA5 in Breast Cancer: An Effective Diagnosis and Prognosis Biomarker

综合分析阐明了CDCA5在乳腺癌中的作用：一种有效的诊断和预后生物标志物

期刊:International Journal of Genomics
影响因子:1.9
doi:10.1155/2023/7150141
Gao, Yang; Liu, Shuting; Yang, Junyuan; Su, Min; Xu, Jingjing; Wang, Hua; Zhang, Jingwei
CDCA5
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏